BB Biotech AG operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BB Biotech AG with three other
miscellaneous service companies in Europe:
Pharma Mar SA
sales of 193.82 million Euro [US$205.53 million]
of which 65%
was Biotech Sector),
Clinigen Group PLC
of the United Kingdom
(£184.36 million [US$229.59 million]
of which 61%
was Clinical Trial services), and
Bachem Holding AG
(208.60 million Swiss Francs [US$207.57 million]
of which 84%
was Active Pharmaceutical Ingredients).